# Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants

> **NCT03197376** · PHASE3 · COMPLETED · sponsor: **PATH** · enrollment: 2250 (actual)

## Conditions studied

- Pneumonia, Pneumococcal

## Interventions

- **BIOLOGICAL:** Pneumosil
- **BIOLOGICAL:** Synflorix

## Key facts

- **NCT ID:** NCT03197376
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-21
- **Primary completion:** 2018-06-06
- **Final completion:** 2019-05-09
- **Target enrollment:** 2250 (ACTUAL)
- **Last updated:** 2020-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03197376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03197376, "Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03197376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*